Nexgel (NXGL) Cash from Operations Growth (3y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 34.91% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 53.64% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 25.17% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -13.33% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 16.13% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -8.92% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -23.67% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 6.48% |
| 10 | Nexgel | 31,199.58 | -1.34 Mn | 819,000.00 | 34.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.81% |
| Sep 30, 2025 | 2.54% |
| Jun 30, 2025 | 16.46% |
| Mar 31, 2025 | 20.53% |
| Dec 31, 2024 | 10.47% |
| Sep 30, 2024 | -32.48% |
| Jun 30, 2024 | -0.58% |
| Mar 31, 2024 | -46.83% |
| Dec 31, 2023 | -11.54% |
| Sep 30, 2023 | -22.02% |
| Jun 30, 2023 | -56.09% |
| Mar 31, 2023 | -2.42% |
| Dec 31, 2022 | -18.81% |
| Sep 30, 2022 | -46.81% |
| Mar 31, 2022 | -12.75% |
| Dec 31, 2021 | -86.46% |
| Sep 30, 2021 | 20.98% |